Skip to main content

Table 2 Immunophenotype comparison between CDKN2 wild-type and deletion

From: Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia

Positive antigens CDKN2 deletion (n = 42) No CDKN2 deletion (n = 85) P value
CD34 40 (95.2 %) 75 (88.2 %) 0.334
HLA-DR 42 (100 %) 81 (95.3 %) 0.301
CD45 20 (47.6 %) 28 (32.9 %) 0.109
TdT 2 (4.8 %) 2 (2.4 %) 0.599
CD117 2 (4.8 %) 1 (1.2 %) 0.254
CD10 40 (95.2 %) 79 (92.9 %) 1.000
CD19 41 (97.6 %) 82 (96.5 %) 1.000
CD20a 25 (59.5 %) 24 (28.2 %) 0.001
CD22 22 (52.4 %) 53 (62.4) 0.282
CD13 24 (57.1 %) 61 (71.8 %) 0.099
CD14 0 (0 %) 3 (3.5 %) 0.550
CD15 0 (0 %) 0 (0 %) N/A
CD33 24 (57.1 %) 34 (40 %) 0.068
CD2 3 (7.1 %) 5 (5.9 %) 1.000
CD3 1 (2.4 %) 0 (0 %) 0.331
CD7 0 (0 %) 4 (4.7 %) 0.301
CD56 4 (9.5 %) 4 (4.7 %) 0.438
CD64 2 (4.8 %) 5 (5.9 %) 1.000
CD11b 3 (7.1 %) 3 (3.5 %) 0.396
cCD79a 38 (90.5 %) 67 (78.8 %) 0.103
cMPO 0 (0 %) 0 (0 %) N/A
  1. aComparison between CDKN2 deletion carriers and non-carriers